IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 402 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $714,948 | -8.4% | 15,001 | -16.7% | 0.00% | +100.0% |
Q1 2024 | $780,300 | -3.6% | 18,000 | +12.5% | 0.00% | -75.0% |
Q4 2023 | $809,491 | +174.5% | 16,001 | +146.1% | 0.00% | +300.0% |
Q3 2023 | $294,931 | -82.7% | 6,502 | -83.1% | 0.00% | -85.7% |
Q3 2022 | $1,703,000 | -62.2% | 38,500 | -51.6% | 0.01% | -30.0% |
Q4 2020 | $4,500,000 | +13.7% | 79,585 | -4.6% | 0.01% | 0.0% |
Q3 2020 | $3,957,000 | -11.3% | 83,391 | +10.2% | 0.01% | -37.5% |
Q2 2020 | $4,460,000 | -48.6% | 75,640 | -58.8% | 0.02% | -69.2% |
Q1 2020 | $8,683,000 | -28.0% | 183,647 | -8.0% | 0.05% | -16.1% |
Q4 2019 | $12,060,000 | -31.1% | 199,634 | -31.7% | 0.06% | -43.1% |
Q3 2019 | $17,507,000 | +55.8% | 292,227 | +67.2% | 0.11% | +45.3% |
Q2 2019 | $11,234,000 | -15.7% | 174,798 | +6.5% | 0.08% | -3.8% |
Q1 2019 | $13,328,000 | +140.2% | 164,200 | +60.0% | 0.08% | +122.9% |
Q4 2018 | $5,548,000 | +4.1% | 102,615 | -0.7% | 0.04% | +45.8% |
Q3 2018 | $5,328,000 | – | 103,308 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |